Summary by Moomoo AI
Kozai Pharmaceuticals-B (share code: 2171) issued a supplementary notice on 30 April 2024 mentioning that the Annual General Meeting will be held in Shanghai on 21 May 2024. The supplementary notice is a supplement to the Circular and the original notice issued earlier on 18 April and will take into account the additional ordinary resolution, namely the re-election of Dr Zhou Wen as an independent non-executive director. The Supplemental Circular also includes a revised proxy form and provides guidance on the completion and submission of the form. In addition, the notice reminds shareholders of details concerning the suspension of share transfer registration, eligibility to attend the general meeting, appointment of representatives, etc., which were described in the original notice. The Board of Directors of the Company includes Executive Directors Dr. Lee Zonghai, Dr. Wang Huamao and Dr. Jiang Wah; Non-Executive Directors Mr. Guo Pingsen, Mr. Kwok Huaqing and Mr. Hie Binggang; Independent Non-Executive Directors Dr. Yan Kwang-mei, Ms. Zhao Xiangko and Dr. Zhou Wen.